These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 24656024

  • 21. Regression of IgA nephropathy: a repeat biopsy study.
    Hotta O, Furuta T, Chiba S, Tomioka S, Taguma Y.
    Am J Kidney Dis; 2002 Mar; 39(3):493-502. PubMed ID: 11877568
    [Abstract] [Full Text] [Related]

  • 22. [Tonsillectomy in recurrent IgA nephropathy after renal transplantation].
    Kurata N, Takahashi M, Koda H.
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Jan; 115(1):29-36. PubMed ID: 22413484
    [Abstract] [Full Text] [Related]

  • 23. Latent IgA deposition from donor kidneys does not affect transplant prognosis, irrespective of mesangial expansion.
    Sofue T, Inui M, Hara T, Moritoki M, Nishioka S, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Kushida Y, Haba R, Nishiyama A, Kakehi Y, Kohno M.
    Clin Transplant; 2013 Jan; 27 Suppl 26():14-21. PubMed ID: 24299231
    [Abstract] [Full Text] [Related]

  • 24. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
    [Abstract] [Full Text] [Related]

  • 25. Proliferative glomerulonephritis with monoclonal immunoglobulin A light-chain deposits in the renal allograft.
    Setoguchi K, Kawashima Y, Tokumoto T, Toma H, Mizoguchi S, Horita S, Yamaguchi Y, Tanabe K.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():49-51. PubMed ID: 24842824
    [Abstract] [Full Text] [Related]

  • 26. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M.
    J Clin Exp Hematop; 2012 Jun; 52(3):161-70. PubMed ID: 23269075
    [Abstract] [Full Text] [Related]

  • 27. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR.
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [Abstract] [Full Text] [Related]

  • 28. The role of tonsillectomy in IgA nephropathy.
    Feriozzi S, Polci R.
    J Nephrol; 2016 Feb; 29(1):13-9. PubMed ID: 26582216
    [Abstract] [Full Text] [Related]

  • 29. The role of tonsillectomy in pediatric IgA nephropathy.
    Mariotti AJ, Agrawal R, Hotaling AJ.
    Arch Otolaryngol Head Neck Surg; 2009 Jan; 135(1):85-7. PubMed ID: 19153312
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y, Ishida H, Shimizu T, Tanabe K.
    Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY, Ku FM, Kuo YC, Chen CF, Chen WP, Chen A, Shiao MS.
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [Abstract] [Full Text] [Related]

  • 32. Latent mesangial immunoglobulin A deposition in long-term functioning kidney does not correlate with disease progression and may exhibit fluctuating patterns.
    Hara S, Ichimaru N, Kyo M, Yamaguchi Y, Kojima Y, Takahara S, Itoh T.
    Transplant Proc; 2014 Jan; 46(1):124-9. PubMed ID: 24507037
    [Abstract] [Full Text] [Related]

  • 33. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification.
    Hirano K, Amano H, Kawamura T, Watanabe K, Koike K, Shimizu A, Endo S, Tsuboi N, Okonogi H, Miyazaki Y, Ikeda M, Hanaoka K, Ogura M, Komatsumoto S, Yokoo T.
    Clin Exp Nephrol; 2016 Jun; 20(3):425-32. PubMed ID: 26415960
    [Abstract] [Full Text] [Related]

  • 34. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells.
    Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN.
    J Lab Clin Med; 2002 Dec; 140(6):398-406. PubMed ID: 12486407
    [Abstract] [Full Text] [Related]

  • 35. Clinicopathological study of the effectiveness of tonsillectomy in IgA nephropathy accompanied by chronic tonsillitis.
    Sugiyama N, Shimizu J, Nakamura M, Kiriu T, Matsuoka K, Masuda Y.
    Acta Otolaryngol Suppl; 1993 Dec; 508():43-8. PubMed ID: 8285042
    [Abstract] [Full Text] [Related]

  • 36. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 37. [Study of IgA nephropathy in the transplanted kidney--sequential changes in mesangial IgA deposits found one hour post-transplantation kidney biopsies].
    Sugiyama S, Yamamoto T, Tsuyuki M, Ohshima S.
    Nihon Jinzo Gakkai Shi; 1986 Jun; 28(6):729-37. PubMed ID: 3534380
    [No Abstract] [Full Text] [Related]

  • 38. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I, Hayashi T, Sato KK, Shibata MO, Hamada M, Kishida M, Kitabayashi C, Morikawa T, Okada N, Okumura M, Konishi M, Konishi Y, Endo G, Imanishi M.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [Abstract] [Full Text] [Related]

  • 39. Effect and therapeutic mechanisms of tonsillectomy for childhood IgA nephropathy.
    Nishi H, Sugimoto K, Fujita S, Miyazaki K, Miyazawa T, Sakata N, Okada M, Takemura T.
    Nephrology (Carlton); 2012 Sep; 17(7):658-64. PubMed ID: 22616843
    [Abstract] [Full Text] [Related]

  • 40. Molecular basis of IgA nephropathy.
    Lai AS, Lai KN.
    Curr Mol Med; 2005 Aug; 5(5):475-87. PubMed ID: 16101476
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.